课题基金 / 基金详情

CAREER: Rational Design of Immune Cell-Homing Biomaterials for Immune Regulation

CAREER: Rational Design of Immune Cell-Homing Biomaterials for Immune Regulation
职业:用于免疫调节的免疫细胞归巢生物材料的合理设计
批准号:
2143673
负责人:
Hua Wang
金额:
$69.69万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2027-02-28

项目摘要

项目成果

Hua Wang的其他基金

相似基金

相关文献

中文摘要
翻译
该奖项的全部或部分资金来自2021年美国救援计划法案(公法117-2)非技术摘要:引入人体的生物材料通常会引起免疫反应,可能导致功能障碍或材料排斥。过去的研究工作主要集中在减少或消除免疫反应,即,使生物材料对免疫系统不可见。然而,这种被动的方法无法捕捉和利用免疫反应的积极方面,而免疫反应可以改善生物材料在许多疾病背景下的性能。该项目旨在了解如何利用大孔生物材料来招募特定类型的免疫细胞(例如,树突状细胞和T细胞;体内两种突出的免疫细胞),可以在材料部位进一步训练,以更好地对抗癌细胞和病原体。通过假设免疫细胞募集受材料的物理性质(包括孔径和力学)的影响,本项目将开发一种大孔生物材料,能够独立调节孔径,刚度和粘度,阐明每个参数对免疫细胞募集的影响,并进一步合理设计可主要富集树突细胞或T细胞的材料。这项研究的潜在成果将是精确控制人体免疫反应的新技术,用于治疗难以用现有疗法驯服的癌症的有效癌症免疫疗法,以及用于开发未来自身免疫性疾病,传染病和损伤组织的免疫疗法的生物材料平台。这些研究工作将与教育和推广活动相结合,包括为中学生,高中生和新生开发生物材料讲座和演示。它旨在提高人们对生物材料教育重要性的认识,以适应材料科学在生物医学中日益增长的影响。鉴于在新冠肺炎疫情期间,人们缺乏免疫学和疫苗的一般知识,我们将从工程学的角度开发免疫学模块,并将其引入课堂和夏令营,以教育下一代免疫学和疫苗接种的基本概念。技术摘要:利用趋化因子的新概念-负载的大孔生物材料原位主动募集和编程所需的免疫细胞,从而调节全身免疫应答,开发有效的免疫疗法来对抗疾病。然而,免疫细胞募集概况,即,不同免疫细胞的数量和比例,材料的数量和比例是不可预测的。该项目将阐明免疫细胞在大孔材料中的募集和富集机制以及材料特性对免疫细胞行为的影响。材料的孔径、力学和趋化因子释放动力学可能决定了免疫细胞的募集概况,但独立和灵活地控制这些参数仍然是一个挑战。本项目将开发一种能够独立调节孔径、刚度、粘度和趋化因子释放动力学的大孔水凝胶系统(目标1),阐明各参数对体外免疫细胞募集、迁移和增殖的影响,并进一步合理设计能够主要富集树突状细胞或T细胞的材料(目标2),并验证他们开发有效的癌症免疫疗法的承诺(目标3)。该项目的成功完成将使大孔材料的合理设计能够优先富集特定类型的免疫细胞,以精确协调不同疾病背景下的免疫反应。此外,研究工作将与各级学生的教育培训相结合,特别是通过促进生物材料教育,以适应材料科学在生物医学中日益增长的影响,并从工程角度教育下一代免疫学和疫苗接种的基本概念。该奖项反映了NSF的法定使命,并通过使用基金会的知识产权进行评估,被认为值得支持。优点和更广泛的影响审查标准。
英文摘要
This award is funded in whole or in part under the American Rescue Plan Act of 2021 (Public Law 117-2)Non-Technical Summary:Biomaterials introduced into the human body often cause immune responses that may result in the dysfunction or rejection of materials. Past research effort has been largely focused on reducing or eliminating the immune responses, i.e., making the biomaterials invisible to the immune system. However, this passive approach fails to capture and leverage the positive side of immune responses, which can instead improve the performance of biomaterials in many disease contexts. This project aims to understand how macroporous biomaterials can be utilized to recruit specific types of immune cells (e.g., dendritic cells and T cells; two prominent types of immune cells in the body), which can be further trained at the material site to better combat cancer cells and pathogens. By hypothesizing that immune cell recruitment is affected by the physical properties of materials, including pore size and mechanics, this project will develop a macroporous biomaterial that enables independent tuning of pore size, stiffness, and viscosity, elucidate the impact of each parameter on the immune cell recruitment, and further rationally design materials that can primarily enrich dendritic cells or T cells. Potential outcomes from this research will be new technologies to precisely control the body’s immune responses, effective cancer immunotherapies for treating cancers that are difficult to tame with existing therapies, and a biomaterial platform for developing future immunotherapies for autoimmune disorders, infectious diseases, and injured tissues. These research efforts will be integrated with education and outreach activities, including the development of biomaterial lectures and demos for middle-school students, high-school students, and freshmen. It aims to raise the awareness of the importance of biomaterials education to match the increasing impact of material science in biomedicine. In view of the lack of general knowledge about immunology and vaccine, as reflected during the covid-19 pandemic, immunology modules will be developed from an engineering perspective and introduced to classes and summer camps to educate the next generation with basic concepts of immunology and vaccination.Technical Summary:The emerging concept of utilizing chemokine-loaded macroporous biomaterials to actively recruit and program desired immune cells in situ and thus regulate systemic immune responses has shown great promise for developing effective immunotherapies against diseases. However, the immune cell recruitment profile, i.e., numbers and fractions of different immune cells, of materials has been unpredictable. This project will elucidate the mechanism for immune cell recruitment and enrichment within macroporous materials and the impact of material properties on immune cell behaviors. Pore size, mechanics, and chemokine release kinetics of materials likely dictate the immune cell recruitment profile, but independent and flexible control of these parameters remains a challenge. This project will develop a macroporous hydrogel system that enables independent tuning of pore size, stiffness, viscosity, and chemokine release kinetics (Aim 1), elucidate the impact of each parameter on the immune cell recruitment, migration, and proliferation in vitro and further rationally design materials that can primarily enrich dendritic cells or T cells (Aim 2), and validate their promise for developing potent cancer immunotherapy (Aim 3). Successful completion of this project will enable rational design of macroporous materials that can preferentially enrich specific types of immune cells, for precise orchestration of immune responses in different disease contexts. Additionally, the research efforts will be integrated with the educational training of students at all levels, especially by promoting biomaterials education to match the rising impact of materials science in biomedicine and educating the next generation with basic concepts of immunology and vaccination from an engineering perspective.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s12195-023-00770-2
发表时间: 2023-07-03
期刊: CELLULAR AND MOLECULAR BIOENGINEERING
影响因子: 2.8
作者: [Han,Joonsu, Bhatta,Rimsha, Wang,Hua]
通讯作者: Wang,Hua
DOI: 10.1016/j.actbio.2022.07.028
发表时间: 2022-08-31
期刊: ACTA BIOMATERIALIA
影响因子: 9.7
作者: [Han, Joonsu, Park, Jihoon, Wang, Hua]
通讯作者: Wang, Hua
DOI: 10.1016/j.jconrel.2022.05.007
发表时间: 2022-05-11
期刊: JOURNAL OF CONTROLLED RELEASE
影响因子: 10.8
作者: [Bhatta,Rimsha, Han,Joonsu, Wang,Hua]
通讯作者: Wang,Hua
Spotlight—author’s view for “Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumorefficacy of dendritic cell vaccine”
Spotlight——作者对“代谢聚糖标记固定树突状细胞膜并增强树突状细胞疫苗的抗肿瘤功效”的观点
DOI: 10.1038/s41435-023-00245-4
发表时间: 2023
期刊: Genes & Immunity
影响因子: 5
作者: [Zhou, Jiadiao, Wang, Hua]
通讯作者: Wang, Hua
S&AS: INT: COLLAB: An Intelligence-Driven Patient Care Approach to Reduce Medical Errors (I-CARE)
  • 批准号:
    1849359
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2019
  • 负责人:
    Hua Wang
  • 依托单位:
CAREER: Robust Brain Imaging Genomics Data Mining Framework for Improved Cognitive Health
  • 批准号:
    1652943
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $40.96万
  • 财政年份:
    2017
  • 负责人:
    Hua Wang
  • 依托单位:
Technical Exchange Meeting on Semiconductor Platforms for Synthetic Biology and Hybrid Bioelectronic Systems, July27-28,2016 at Georgia Institute of Technology in Atlanta, GA
  • 批准号:
    1642181
  • 项目类别:
    Standard Grant
  • 资助金额:
    $1.5万
  • 财政年份:
    2016
  • 负责人:
    Hua Wang
  • 依托单位:
Collaborative Research: A Hybrid Biological-Microelectronic Pacemaker
  • 批准号:
    1610677
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.5万
  • 财政年份:
    2016
  • 负责人:
    Hua Wang
  • 依托单位:
国内基金
海外基金
基于Rational Krylov法和小波域稀疏约束的时间域海洋电磁三维正反演研究
  • 批准号:
    41804098
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2018
  • 负责人:
    张博
  • 依托单位:
基于Rational-Tensor(RTCam)摄像机模型的序列图像间几何框架研究
  • 批准号:
    61072105
  • 项目类别:
    面上项目
  • 资助金额:
    29.0万元
  • 批准年份:
    2010
  • 负责人:
    沈沛意
  • 依托单位: